Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-16-012631
Filing Date
2016-04-18
Accepted
2016-04-18 17:24:45
Documents
1
Period of Report
2016-04-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4041416steinhart_actinium.html 4  
1 OWNERSHIP DOCUMENT f4041416steinhart_actinium.xml 4 5471
  Complete submission text file 0001213900-16-012631.txt   6921
Mailing Address 125 ELM STREET NEW CANAAN CT 06840
Business Address
Steinhart Richard I (Reporting) CIK: 0001293789 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 161577517

Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations